Lanean...

Adoptive Cellular Therapy using Cells Enriched for NKG2D(+)CD3(+)CD8(+)T Cells after Autologous Transplantation for Myeloma

The number of circulating lymphocytes on day 15 after transplantation correlates with improved survival in patients with myeloma, but the lymphocyte subset responsible is unknown. NKG2D is a natural killer (NK) cell activating receptor that mediates non-MHC restricted and TCR-independent cell lysis....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Meehan, Kenneth R., Talebian, Laleh, Tosteson, Tor D., Hill, John M., Szczepiorkowski, Zbigniew, Sentman, Charles L., Ernstoff, Marc S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3772513/
https://ncbi.nlm.nih.gov/pubmed/22975165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.08.018
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!